AstraZeneca WITHDRAWS COVID-19 injection worldwide after admitting it causes BLOOD CLOTS

05/14/2024 / By Ava Grace

AstraZeneca has announced the global withdrawal of its Wuhan coronavirus (COVID-19) injection, following the company’s admission that it causes severe side effects.

According to the National Pulse, the Anglo-Swedish drug firm applied for a withdrawal of its vaccine’s marketing authorization in the European Union back in March. The European Medicines Agency (EMA), the agency in charge of regulating vaccines in the union, approved the request – which took effect on May 7. Similar moves in the U.K. and other countries were expected.

In an update on the EMA’s website, it said the approval for the AstraZeneca COVID-19 injection had been withdrawn “at the request of the marketing authorization holder.” Marco Cavaleri, head of vaccine strategy at the European regulator, said he expected all the “monovalent” vaccines – which dealt only with the original SARS-CoV-2 strain – to be withdrawn in time.

“The authorization of the [COVID-19 vaccine] by AstraZeneca will be withdrawn, and the process has already officially started with the European Commission,” he told Italian media outlets. “This is in line with the expectations that no-longer-used and updated vaccines will be withdrawn as per our indication.”

Described by former British Prime Minister Boris Johnson as a “triumph for British science,” the AstraZeneca COVID-19 injection was first approved by the EMA in January 2021. However, concerns grew about the vaccine’s safety within weeks when dozens of countries suspended its use following the detection of blood clots in those injected with the vaccine.

Billions of doses of the AstraZeneca vaccine were distributed to poorer countries through a U.N.-coordinated program, as it was cheaper and easier to produce and distribute. However, studies later suggested that the pricier messenger RNA vaccines made by Pfizer and Moderna provided better protection against COVID-19 and its many variants, and most countries switched to those.

AstraZeneca claims withdrawal due to “commercial reasons”

AstraZeneca claims that the decision was due to “commercial reasons,” with new injections having superseded its initial offering. But critics point out that the withdrawal followed an admission by the pharmaceutical company that its COVID-19 injection – sold under the names Vaxzevria and Covishield – can cause thrombosis with thrombocytopenia syndrome (TTS). The condition, which involves blood clots coupled with a low blood platelet count, is linked to 81 fatalities in the United Kingdom.

“It is admitted that the [AstraZeneca] vaccine can … cause TTS,” the company indicated in recent court filings. Despite this, the Anglo-Swedish pharmaceutical firm insisted that TTS only happens “in very rare cases.” The admission was in relation to a lawsuit alleging that AstraZeneca’s COVID-19 injection was defective. (Related: AstraZeneca admits its COVID-19 vaccine CAUSES BLOOD CLOTS in U.K. court filings).

The lawsuit was filed by Jamie Scott, a 47-year-old who suffered permanent brain damage after being injected with the COVID-19 vaccine. His wife Kate responded to the news of the withdrawal, telling the Telegraph: “They say it is for commercial reasons, but maybe it’s because it can no longer be seen as being within the acceptable safety parameters, with 445 confirmed cases of [vaccine-induced immune thrombocytopenia and thrombosis], 81 of these fatal in the U.K. alone.”

Still, Kate was happy with this development. “AstraZeneca’s COVID-19 vaccine no longer being used in the U.K. or Europe, and soon the rest of the world, means no one else will suffer from this awful adverse reaction,” she said.

Watch this video about the AstraZeneca COVID-19 vaccine being pulled out after being linked to blood clots and turbo cancer.

This video is from the Puretrauma357 channel on Brighteon.com.